Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT01484314. IPD Sharing: NO. Countries: 1. Publications: 0.
Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma
ClinicalTrials.gov study NCT00523848. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation
ClinicalTrials.gov study NCT03417284. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)
ClinicalTrials.gov study NCT03984097. IPD Sharing: YES. Countries: 1. Publications: 0.
Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma
ClinicalTrials.gov study NCT00948922. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pomalidomide in Gene Expression Profiling (GEP)-Defined High-risk Multiple Myeloma
ClinicalTrials.gov study NCT01177735. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT03012880. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Autologous Transplantation for Multiple Myeloma
ClinicalTrials.gov study NCT00378222. IPD Sharing: Not stated. Countries: 0. Publications: 0.
S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00124579. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors
ClinicalTrials.gov study NCT01457417. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma
ClinicalTrials.gov study NCT02477891. IPD Sharing: Not stated. Countries: 6. Publications: 2.
Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01348919. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of Ibrutinib in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed/Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02902965. IPD Sharing: NO. Countries: 6. Publications: 0.
Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma
ClinicalTrials.gov study NCT01110135. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01646762. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prevention of Treatment Induced Neuropathy in Multiple Myeloma
ClinicalTrials.gov study NCT01283997. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Sig
ClinicalTrials.gov study NCT06140524. IPD Sharing: YES. Countries: 2. Publications: 0.
Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT)
ClinicalTrials.gov study NCT05130827. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of MCARH109 and MCARH125 in People With Multiple Myeloma
ClinicalTrials.gov study NCT05431608. IPD Sharing: YES. Countries: 1. Publications: 0.
Oral ONC201 in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02863991. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.